Viewing nowDongkwang Montelukast Chewable Tablet 4mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

MFDS item code 201307821 · Approved 2013.06.25 · Insurance code 645905440
Prevention and maintenance treatment of asthma; relief of allergic rhinitis symptoms
Helps prevent the occurrence of asthma and provides continuous treatment. Also used to relieve symptoms of seasonal and perennial allergic rhinitis.
This medicine should be taken once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the dosing time should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. Adults and adolescents aged 15 years and older: Administer montelukast 10 mg orally once daily. Adults and adolescents aged 15 years and older: Place montelukast 10 mg on the tongue once daily, allow it to dissolve, and take without water.
Children aged 6~14 years: Take 5 mg of montelukast once daily by chewing. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Take 4 mg of montelukast once daily by chewing. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily and take without water after it disintegrates. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily and take without water after it disintegrates. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Place 5 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Place 4 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 6~14 years: Administer 5mg of montelukast orally once daily. Administer this medicine 1 hour before or 2 hours after a meal. Asthma, children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Asthma, infants aged 12 months~under 2 years: Administer 4 mg of this medicine orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. Allergic rhinitis, children aged 2~5 years: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Allergic rhinitis, infants aged 6 months~under 2 years: Administer 4mg of this medicine orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age.
This medication contains the artificial sweetener aspartame, and should be avoided in patients with the genetic disorder phenylketonuria. The intake of aspartame should be limited to below the WHO recommended levels, with a maximum daily limit of 2.4 grams for adults. Additionally, due to the presence of lactose in this medication, it should not be taken by patients with genetic issues such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. This medication is not intended for treating acute asthma attacks, therefore a separate appropriate emergency medication should be prepared if acute symptoms occur. When reducing the dosage of inhaled corticosteroids, this must be done progressively according to a doctor's instructions, and should not be abruptly substituted. While taking this medication, patients may experience neuropsychiatric symptoms, so the patient or caregiver should notify the doctor immediately if any changes occur. In cases of exercise-induced bronchospasm, this medication alone should not be used for treatment, and inhaled beta-agonists should continue to be used, with preparations made for emergency situations. Patients with hypersensitivity to aspirin should not take aspirin or non-steroidal anti-inflammatory drugs while taking this medication. Rarely, serious adverse effects such as vasculitis or eosinophilia may occur, and physicians should carefully monitor the patient. While drug interactions during treatment are minimal, caution should be exercised when used in conjunction with certain liver enzyme inducers. This medication should only be taken during pregnancy when clearly necessary, and nursing women should use it with caution. Both children and the elderly can take this medication, but they should follow a doctor's recommendations regarding safety and dosage adjustments based on age. There is no specific antidote for overdose, so general treatment should be administered according to symptoms, and medical attention should be sought. This medication is sensitive to light, so do not open until right before dosing, and take within 15 minutes after preparation. When storing, keep it out of the reach of children and do not transfer it to another container. Lastly, this medication should be taken consistently even when asthma symptoms are not present, and if symptoms worsen, a consultation with a physician is required.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to moisture and light, so it should be stored at room temperature between 1 °C and 30 °C. It is also crucial to store it in a container that is tightly closed to prevent air exposure.
Pink, biconvex, oval-shaped chewable tablet
28 tablets/box [7 tablets/PTP × 4]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.